Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,561 | 281 | 97.1% |
| Education | $194.26 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,340 | 68 | $0 (2024) |
| GENZYME CORPORATION | $919.47 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $601.71 | 20 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $596.03 | 19 | $0 (2024) |
| PFIZER INC. | $451.94 | 21 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $434.17 | 26 | $0 (2024) |
| UCB, Inc. | $422.51 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $401.58 | 18 | $0 (2024) |
| Amgen Inc. | $298.45 | 13 | $0 (2024) |
| Lilly USA, LLC | $280.58 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,499 | 110 | ABBVIE INC. ($395.39) |
| 2023 | $2,456 | 94 | ABBVIE INC. ($495.40) |
| 2022 | $1,251 | 55 | ABBVIE INC. ($302.76) |
| 2021 | $548.62 | 25 | AbbVie Inc. ($146.21) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.92 | General |
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Immunology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.75 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $85.96 | General |
| Category: Inflammation & Immunology | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Immunology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $37.43 | General |
| Category: Dermatology | ||||||
| 10/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: DERMATOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 524 | 802 | $77,892 | $26,620 |
| 2022 | 12 | 362 | 540 | $46,591 | $17,145 |
| 2021 | 9 | 495 | 866 | $97,165 | $33,738 |
| 2020 | 11 | 624 | 1,125 | $120,077 | $37,856 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 99 | 105 | $16,616 | $5,384 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 67 | $13,532 | $5,071 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 62 | $9,221 | $3,613 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $8,983 | $3,247 | 36.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 85 | 105 | $11,095 | $2,879 | 25.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 53 | $4,057 | $1,366 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $3,736 | $1,312 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 64 | 287 | $3,054 | $1,115 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 31 | $2,628 | $1,025 | 39.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 13 | $2,358 | $808.50 | 34.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $2,612 | $799.17 | 30.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 68 | 73 | $10,181 | $3,469 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 34 | $5,677 | $2,512 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,092 | $1,611 | 31.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 48 | 58 | $5,262 | $1,537 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 36 | $2,548 | $1,290 | 50.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 34 | 42 | $2,977 | $1,257 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $3,924 | $1,212 | 30.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 30 | 30 | $2,810 | $1,096 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $3,156 | $1,016 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 11 | 11 | $1,508 | $810.68 | 53.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 35 | 177 | $1,575 | $729.14 | 46.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $1,882 | $604.98 | 32.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 104 | 135 | $28,216 | $8,888 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 84 | $14,879 | $6,981 | 46.9% |
About Candace Marin, ARNP
Candace Marin, ARNP is a Family healthcare provider based in Sanford, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1164918470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Candace Marin, ARNP has received a total of $6,755 in payments from pharmaceutical and medical device companies, with $2,499 received in 2024. These payments were reported across 284 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($6,561).
As a Medicare-enrolled provider, Marin has provided services to 2,005 Medicare beneficiaries, totaling 3,333 services with total Medicare billing of $115,358. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Sanford, NC
- Active Since 07/10/2018
- Last Updated 04/07/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1164918470
Products in Payments
- DUPIXENT (Biological) $1,399
- RINVOQ (Biological) $665.76
- SKYRIZI (Biological) $523.65
- Sotyktu (Drug) $401.58
- Zoryve (Drug) $347.38
- EUCRISA (Drug) $337.99
- Otezla (Drug) $298.45
- OPZELURA (Drug) $231.57
- ILUMYA (Biological) $222.94
- TALTZ (Drug) $217.81
- Cimzia (Drug) $204.18
- ADBRY (Biological) $159.17
- HUMIRA (Biological) $150.35
- Bimzelx (Biological) $123.65
- CIBINQO (Drug) $113.95
- Winlevi (Drug) $113.33
- TREMFYA (Drug) $86.52
- REMICADE (Biological) $85.77
- OLUMIANT (Drug) $62.77
- VTAMA (Drug) $46.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sanford
Bridget Condit, Fnp, FNP
Family — Payments: $5,776
Bianca Carroll, Np, NP
Family — Payments: $3,654
Amie Motley, Fnp, FNP
Family — Payments: $3,613
Camille Hazlewood
Family — Payments: $2,308
Latandra Rhule, Np-C, NP-C
Family — Payments: $2,160
Madison Cobb, Fnp, FNP
Family — Payments: $2,142